Abl family kinases regulate endothelial barrier function in vitro and in mice

Area of Science:

• Vascular Biology
• Cell Signaling
• Pharmacology

Background:

• Endothelial barrier integrity is crucial for physiological homeostasis.
• Increased vascular permeability underlies various pathologies, causing edema and tissue damage.
• Imatinib, a tyrosine kinase inhibitor, shows protective effects but its specific targets in vascular permeability are unclear.

Purpose of the Study:

• To elucidate the direct role of Abl kinase in regulating endothelial permeability in vivo.
• To investigate the mechanisms by which Abl kinase influences vascular barrier function.
• To assess the therapeutic potential of Abl kinase inhibition for vascular leakage disorders.

Main Methods:

• Utilized endothelial Abl knockout mice for in vivo studies.
• Employed Abl/Arg-specific pharmacological inhibition in vitro and in vivo.
• Analyzed endothelial permeability in response to vascular endothelial growth factor, thrombin, and histamine.
• Investigated downstream signaling pathways including GTPase activation, calcium mobilization, and acto-myosin contractility.

Main Results:

• Demonstrated a direct role for Abl kinase in regulating vascular permeability in vivo.
• Showed that Abl kinase activity is required for endothelial permeability induced by vascular endothelial growth factor.
• Confirmed that Abl kinase inhibition reduces permeability triggered by inflammatory mediators like thrombin and histamine.
• Identified activation of Rac1 and Rap1 GTPases and inhibition of calcium mobilization and contractility upon Abl kinase loss.

Conclusions:

• Abl kinase plays a critical role in controlling endothelial barrier function.
• Targeting Abl kinases can inhibit endothelial permeability induced by diverse agonists.
• Abl kinase inhibitors represent a potential therapeutic strategy for pathological vascular leakage.